Bruker (BRKR) Equity Average (2011 - 2026)

Bruker has reported Equity Average for 16 years, with the latest figure at $2.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Equity Average rose 36.1% year-over-year to $2.5 billion; the trailing twelve-month figure through Mar 2026 stood at $2.5 billion (up 36.1% YoY), and the FY2025 full-year result was $2.1 billion, up 33.8% from the prior year.
• Equity Average for Q1 2026 stood at $2.5 billion, up from $2.5 billion in the prior quarter.
• The five-year high for Equity Average was $2.5 billion in Q1 2026, with the low at $966.2 million in Q3 2022.
• Historically, Equity Average has averaged $1.6 billion across 5 years, with a median of $1.4 billion in 2024.
• Annual changes were most pronounced in 2022 — Equity Average declined 8.2% — and 2024, when it surged 46.59%.
• Bruker's Equity Average stood at $1.0 billion in 2022, then rose by 26.43% to $1.3 billion in 2023, then soared by 38.16% to $1.8 billion in 2024, then soared by 35.43% to $2.5 billion in 2025, then rose by 0.72% to $2.5 billion in 2026.
• The last three Equity Average figures came in at $2.5 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.